Cargando…

Controlled release of artemisone for the treatment of experimental cerebral malaria

BACKGROUND: Cerebral malaria (CM) is a leading cause of malarial mortality resulting from infection by Plasmodium falciparum. Treatment commonly involves adjunctive care and injections or transfusion of artemisinins. All artemisinins that are in current use are metabolized to dihydroxyartemisinin (D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golenser, Jacob, Buchholz, Viola, Bagheri, Amir, Nasereddin, Abed, Dzikowski, Ron, Guo, Jintao, Hunt, Nicholas H., Eyal, Sara, Vakruk, Natalia, Greiner, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333427/ https://www.ncbi.nlm.nih.gov/pubmed/28249591 http://dx.doi.org/10.1186/s13071-017-2018-7

Ejemplares similares

Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation
por: Golenser, Jacob, et al.
Publicado: (2020)

Artemisone effective against murine cerebral malaria
por: Waknine-Grinberg, Judith H, et al.
Publicado: (2010)

Elimination of Schistosoma mansoni in infected mice by slow release of artemisone
por: Gold, Daniel, et al.
Publicado: (2017)

Efficient Treatment of Experimental Cerebral Malaria by an Artemisone-SMEDDS System: Impact of Application Route and Dosing Frequency
por: Zech, Johanna, et al.
Publicado: (2021)

Indocyanine Green Liposomes for Diagnosis and Therapeutic Monitoring of Cerebral Malaria
por: Portnoy, Emma, et al.
Publicado: (2016)

Transdermal delivery of artemisinins for treatment of pre-clinical cerebral malaria
por: Zech, Johanna, et al.
Publicado: (2021)

Oral Administration of Artemisone for the Treatment of Schistosomiasis: Formulation Challenges and In Vivo Efficacy
por: Zech, Johanna, et al.
Publicado: (2020)

Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs
por: Bagheri, Amir Reza, et al.
Publicado: (2017)

Use of Peptide Nucleic Acids to Manipulate Gene Expression in the Malaria Parasite Plasmodium falciparum
por: Kolevzon, Netanel, et al.
Publicado: (2014)

Global Health: Unlocking Nanocarriers for the Programmed Release of Antimalarial Drugs (Global Challenges 2/2017)
por: Bagheri, Amir Reza, et al.
Publicado: (2017)

Reduction of Experimental Cerebral Malaria and Its Related Proinflammatory Responses by the Novel Liposome-Based β-Methasone Nanodrug
por: Guo, Jintao, et al.
Publicado: (2014)

Synthesis and biological evaluation of novel artemisone–piperazine–tetronamide hybrids
por: Wei, Meng-Xue, et al.
Publicado: (2021)

Novel 2-Phenoxyanilide Congeners Derived from a Hit Structure of the TCAMS: Synthesis and Evaluation of Their in Vitro Activity against Plasmodium falciparum
por: Weidner, Thomas, et al.
Publicado: (2016)

Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs
por: Wong, Ho Ning, et al.
Publicado: (2020)

Synthesis and Antiplasmodial Activity of Bisindolylcyclobutenediones
por: Lande, Duc Hoàng, et al.
Publicado: (2021)

Endothelial Cells Potentiate Interferon-γ Production in a Novel Tripartite Culture Model of Human Cerebral Malaria
por: Khaw, Loke Tim, et al.
Publicado: (2013)

Neutrophils impose strong immune pressure against PfEMP1 variants implicated in cerebral malaria
por: Zelter, Tamir, et al.
Publicado: (2022)

Antiplasmodial dihetarylthioethers target the coenzyme A synthesis pathway in Plasmodium falciparum erythrocytic stages
por: Weidner, Thomas, et al.
Publicado: (2017)

Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue
por: Ng, Jerome P. L., et al.
Publicado: (2022)

Schistosoma mansoni infection reduces the incidence of murine cerebral malaria
por: Waknine-Grinberg, Judith H, et al.
Publicado: (2010)

Emerging biology of noncoding RNAs in malaria parasites
por: Simantov, Karina, et al.
Publicado: (2022)

Glucocorticosteroids in Nano-Sterically Stabilized Liposomes Are Efficacious for Elimination of the Acute Symptoms of Experimental Cerebral Malaria
por: Waknine-Grinberg, Judith H., et al.
Publicado: (2013)

Mutually Exclusive Expression of Virulence Genes by Malaria Parasites Is Regulated Independently of Antigen Production
por: Dzikowski, Ron, et al.
Publicado: (2006)

Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines
por: Masch, Andreas, et al.
Publicado: (2019)

Cerebral malaria: gamma-interferon redux
por: Hunt, Nicholas H., et al.
Publicado: (2014)

The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage P. falciparum Parasites, DMPK Properties, and the Case for Artemiside
por: Gibhard, Liezl, et al.
Publicado: (2021)

Cisplatin Tumor Biodistribution and Efficacy after Intratumoral Injection of a Biodegradable Extended Release Implant
por: Shikanov, Ariella, et al.
Publicado: (2011)

An SR protein is essential for activating DNA repair in malaria parasites
por: Goyal, Manish, et al.
Publicado: (2021)

Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation
por: Müller, Joachim, et al.
Publicado: (2022)

Phosphorylation of the Canonical Histone H2A Marks Foci of Damaged DNA in Malaria Parasites
por: Goyal, Manish, et al.
Publicado: (2021)

Localised release of matrix metallopeptidase 8 in fatal cerebral malaria
por: Georgiadou, Athina, et al.
Publicado: (2021)

Cerebral Malaria
por: Khan, Najib
Publicado: (1951)

Cerebral Malaria
por: Bhattacharjya, B. P.
Publicado: (1945)

Cerebral Malaria
por: Gupta, B. M. Das
Publicado: (1945)

Differential plasma microvesicle and brain profiles of microRNA in experimental cerebral malaria
por: Cohen, Amy, et al.
Publicado: (2018)

An upstream open reading frame (uORF) signals for cellular localization of the virulence factor implicated in pregnancy associated malaria
por: Fastman, Yair, et al.
Publicado: (2018)

Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria
por: Miranda, Aline S, et al.
Publicado: (2013)

Production, Fate and Pathogenicity of Plasma Microparticles in Murine Cerebral Malaria
por: El-Assaad, Fatima, et al.
Publicado: (2014)

Real-Time Imaging Reveals the Dynamics of Leukocyte Behaviour during Experimental Cerebral Malaria Pathogenesis
por: Pai, Saparna, et al.
Publicado: (2014)

Ethical Concerns of the Veterinarian in Relation to Experimental Animals and In Vivo Research
por: Kiraga, Łukasz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n2go5q6rkgddf1pvucr929rr5a